1. Home
  2. AOMR vs CNXU Comparison

AOMR vs CNXU Comparison

Compare AOMR & CNXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AOMR

Angel Oak Mortgage REIT Inc.

HOLD

Current Price

$9.03

Market Cap

210.5M

Sector

Real Estate

ML Signal

HOLD

Logo Conexeu Sciences Inc. Common Stock

CNXU

Conexeu Sciences Inc. Common Stock

N/A

Current Price

$7.97

Market Cap

215.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AOMR
CNXU
Founded
2018
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Industrial Specialties
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
210.5M
215.9M
IPO Year
2019
2025

Fundamental Metrics

Financial Performance
Metric
AOMR
CNXU
Price
$9.03
$7.97
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$11.08
N/A
AVG Volume (30 Days)
89.9K
132.2K
Earning Date
05-05-2026
N/A
Dividend Yield
14.18%
N/A
EPS Growth
53.85
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.38
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.96
$6.85
52 Week High
$10.14
$13.66

Technical Indicators

Market Signals
Indicator
AOMR
CNXU
Relative Strength Index (RSI) 54.19 43.51
Support Level $8.72 $7.55
Resistance Level $9.24 $10.35
Average True Range (ATR) 0.20 1.14
MACD -0.00 -0.00
Stochastic Oscillator 70.46 33.43

Price Performance

Historical Comparison
AOMR
CNXU

About AOMR Angel Oak Mortgage REIT Inc.

Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in first and second lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation, across interest rate and credit cycles. The company operates in a single operating segment, which is to acquire, invest in, and finance mortgage-related assets.

About CNXU Conexeu Sciences Inc. Common Stock

Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.

Share on Social Networks: